Idiopathic Parkinson's Disease (at Later Stage)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Idiopathic Parkinson's Disease (at Later Stage) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 4

NCT03968744

Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease

Patients suffering of Parkinson's Disease will be treated with 50 mg/day of Safinamide per os for 2 weeks (escalation phase). Then, safinamide will be increased…

Switzerland11 participantsStarted 2019-02-18

Treatment: Safinamide